The relationship between oncogene expression and clinical outcome in endometrial carcinoma

Current Cancer Drug Targets

Volumn 4, Issue 6, 2004, Pages 511-520

  Takai, Noriyuki ^a   Ueda, Tami ^a   Nishida, Masakazu ^a   Nasu, Kaei ^a   Miyakawa, Isao ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPHRIN B2; EPHRIN RECEPTOR B4; INHIBITOR OF DIFFERENTIATION 1; PROTEIN CAMKIV; PROTEIN PLKS; SURVIVIN; TRANSCRIPTION FACTOR ELF 1; TRANSCRIPTION FACTOR ETS 1; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CELL PROLIFERATION; CORRELATION ANALYSIS; DISEASE COURSE; ENDOMETRIUM CARCINOMA; GENE ACTIVITY; GENE EXPRESSION; GENE THERAPY; HISTOPATHOLOGY; HUMAN; MALIGNANT TRANSFORMATION; MYOMETRIUM; NEOVASCULARIZATION (PATHOLOGY); ONCOGENE; PATHOPHYSIOLOGY; PROGNOSIS; PROTEIN EXPRESSION; REGRESSION ANALYSIS; REVIEW; SCORING SYSTEM;

ANIMALS; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ONCOGENES;

EID: 4644225723     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568009043332871     Document Type: Review

References (60)

1. Kounelis, S.; Kapranos, N.; Kouri, E.; Coppola, D.; Papadaki, H.; Jones, M. W. Immunohistochemical Profile of Endometrial Adenocarcinoma: a Study of 61 Cases And Review of the Literature. Mod. Pathol. 2000, 13, 379-388.
2. Takai, N.; Fukuda, J.; Yoshimatsu, J.; Miyakawa, I. Homologous Carcinosarcoma of the Uterine Corpus Associated with Tamoxifen Therapy. Int. J. Clin. Oncol. 2000, 5, 140-143.
3. Takai, N.; Miyazaki, T.; Yoshimatsu, J.; Miyakawa, I. Treatment with a Metallic Endovascular Stent in a Patient with Iliac Venous Stenosis Due to Endometrial Cancer. Arch. Gynecol. Obstet. 2000, 264, 51-53.
4. Takai, N.; Utsunomiya, H.; Kawano, Y.; Nasu, K.; Narahara, H.; Miyakawa, I. Complete Response to Radiation Therapy in a Patient with Chemotherapy- Resistant Ovarian Clear Cell Adenocarcinoma. Arch. Gynecol. Obstet. 2002, 267, 98-100.
5. Takai, N.; Hamanaka, R.; Miyakawa, I. Polo-Like Kinases (Plks) and Cancer. Oncogene 2004, in Press
6. Glover, D. M.; Hagan, I. M.; Tavares, A. A. Polo-Like Kinases: a Team That Plays Throughout Mitosis. Genes Dev. 1998, 12, 3777-3787.
7. Lee, K. S.; Song, S.; Erikson, R. L. The Polo-Box-Dependent Induction of Ectopic Septal Structures By a Mammalian Polo Kinase, Plk, in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 1999, 96, 14360-14365.
8. Hamanaka, R.; Smith, M. R.; O'connor, P. M.; Maloid, S.; Mihalic, K.; Spivak, J. L.; Longo, D. L.; Ferris, D. K. Polo-Like Kinase Is a Cell Cycle-Regulated Kinase Activated During Mitosis. J. Biol. Chem. 1995, 270, 21086-21091.
9. Lane, H. A.; Nigg, E. A. Antibody Microinjection Reveals An Essential Role for Human Polo-Like Kinase 1 (Plk1) in the Functional Maturation of Mitotic Centrosomes. J. Cell Biol. 1996, 135, 1701-1713.
10. Fenton, B.; Glover, D. M. A Conserved Mitotic Kinase Active at Late Anaphase-Telophase in Syncytial Drosophila Embryos. Nature 1993, 363, 637-640.
11. Kumagai, A.; Dunphy, W. G. Purification and Molecular Cloning of Plx1, a Cdc25-Regulatory Kinase from Xenopus Egg Extracts. Science 1996, 273, 1377-1380.
12. Yuan, J.; Horlin, A.; Hock, B.; Stutte, H. J.; Rubsamen-Waigmann, H.; Strebhardt, K. Polo-Like Kinase, a Novel Marker for Cellular Proliferation. Am. J. Pathol. 1997, 150, 1165-1172.
13. Simizu, S.; Osada, H. Mutations in the Plk Gene Lead to Instability of Plk Protein in Human Tumour Cell Lines. Nat. Cell Biol. 2000, 2, 852-854.
14. Lee, M.; Daniels, M. J.; Venkitaraman, A. R. Phosphorylation of Brca2 By Polo-Like Kinase Plk1 Is Regulated by DNA Damage and Mitotic Progression. Oncogene 2004, 23, 865-872.
15. Smith, M. R.; Wilson, M. L.; Hamanaka, R.; Chase, D.; Kung, H.; Longo, D. L.; Ferris, D. K. Malignant Transformation of Mammalian Cells Initiated by Constitutive Expression of the Polo-Like Kinase. Biochem. Biophys. Res. Commun. 1997, 234, 397-405.
16. Elez, R.; Piiper, A.; Giannini, C. D.; Brendel, M.; Zeuzem, S. Polo-Like Kinase 1, a New Target for Antisense Tumor Therapy. Biochem. Biophys. Res. Commun. 2000, 269, 352-356.
17. Mundt, K. E.; Golsteyn, R.; Lane, H. A.; Nigg, E. A. On the Regulation and Function of Human Polo-Like Kinase 1 (Plk1): Effexts of Overexpression On Cell Cycle Progression. Biochem. Biophys. Res. Commun. 1997, 239, 377-385.
18. Conn, C. W.; Hennigan, R. F.; Dai, W.; Sanchez, Y.; Stambrook, P. J. Incomplete Cytokinesis and Induction of Apoptosis by Overexpression of the Mammalian Polo-Like Kinase, Plk3. Cancer Res. 2000, 60, 6826-6831.
19. Yuan, J.; Kramer, A.; Eckerdt, F.; Kaufmann, M.; Strebhardt, K. Efficient Internalization of the Polo-Box of Polo-Like Kinase 1 Fused to An Antennapedia Peptide Results in Inhibition of Cancer Cell Proliferation. Cancer Res. 2002, 62, 4186-4190.
20. Cogswell, J. P.; Brown, C. E.; Bisi, J. E.; Neill, S. D. Dominant-Negative Polo-Like Kinase 1 Induces Mitotic Catastrophe Independent of Cdc25c Function. Cell Growth Differ. 2000, 11, 615-623.
21. Liu, X.; Erikson, R. L. Polo-Like Kinase (Plk) 1 Depletion Induces Apoptosis in Cancer Cells. Proc. Natl. Acad. Sci. USA 2003, 100, 5789-5794.
22. Takai, N.; Yoshimatsu, J.; Nishida, Y.; Narahara, H.; Miyakawa, I.; Hamanaka, R. Expression of Polo-Like Kinase (Plk) in the Mouse Placenta and Ovary. Reprod. Fertil. Dev. 1999, 11, 31-35.
23. Yoshimatsu, J.; Takai, N.; Yoshimatsu, Y.; Narahara, H.; Miyakawa, I.; Hamanaka, R. Immunohistochemical Localization of Polo Like Kinase in Early Human Placenta. Res. Commun. Mol. Pathol. Pharmacol. 1999, 106, 3-12.
24. Takai, N.; Miyazaki, T.; Miyakawa, I.; Hamanaka, R. Polo-Like Kinase Expression in Normal Human Endometrium During the Menstrual Cycle. Reprod. Fertil. Dev. 2000, 12, 59-67.
25. Takai, N.; Miyazaki, T.; Fujisawa, K.; Nasu, K.; Hamanaka, R.; Miyakawa, I. Expression of Polo-Like Kinase in Ovarian Cancer Is Associated with Histological Grade and Clinical Stage. Cancer Lett. 2001, 164, 41-49.
26. Takai, N.; Miyazaki, T.; Fujisawa, K.; Nasu, K.; Hamanaka, R.; Miyakawa, I. Polo-Like Kinase (Plk) Expression in Endometrial Carcinoma. Cancer Lett. 2001, 169, 41-49.
27. Eph Nomenclature Committee. Unified Nomenclature for Eph Family Receptors and Their Ligands, the Ephrins. Cell 1997, 90, 403-404.
28. Zhou, R. The Eph Family Receptors and Ligands. Pharmacol. Ther. 1998, 77, 151-181.
29. Nikolova, Z.; Djonov, V.; Zuereher, G.; Andres, A. C.; Ziemiecki, A. Cell-Type Specific and Estrogen Dependent Expression of the Receptor Tyrosine Kinase Ephb4 and Its Ligand Ephrin-B2 During Mammary Gland Morphogenesis. J. Cell Sci. 1998, 111, 2741-2751.
30. Tang, X. X.; Evans, A. E.; Zhao, H.; Cnaan, A.; London, W.; Conn, S. L.; Brodeur, G. M.; Ikegaki, N. High-Level Expression of Ephb6, Efnb2, and Efnb3 Is Associated with Low Tumor Stage and High Trka Expression in Human Neuroblastomas. Clin. Cancer Res. 1999, 5, 1491-1496.
31. Takai, N.; Miyazaki, T.; Fujisawa, K.; Nasu, K.; Miyakawa, I. Expression of Receptor Tyrosine Kinase Ephb4 and Its Ligand Ephrin-B2 Is Associated with Malignant Potential in Endometrial Cancer. Oncol. Rep. 2001, 8, 567-573.
32. Benezra, R.; Davis, R. L.; Lockshon, D.; Turner, D. L.; Weintraub, H. The Protein Id: a Negative Regulator of Helix-Loop-Helix Dna Binding Proteins. Cell 1990, 61, 49-59.
33. Takai, N.; Miyazaki, T.; Fujisawa, K.; Nasu, K.; Miyakavva, I. Id1 Expression Is Associated with Histological Grade and Invasive Behavior in Endometrial Carcinoma. Cancer Lett. 2001, 165, 185-193.
34. Desprez, P. Y.; Lin, C. Q.; Thomasset, N.; Sympson, C. J.; Bissell, M. J.; Campisi, J. a Novel Pathway for Mammary Epithelial Cell Invasion Induced by the Helix-Loop-Helix Protein Id-1. Mol. Cell Biol. 1998, 18, 4577-4588.
35. Asp, J.; Thornemo, M.; Inerot, S.; Lindahl, A. The Helix-Loop-Helix Transcription Factors Id1 and Id3 Have a Functional Role in Control of Cell Division in Human Normal and Neoplastic Chondrocytes. FEBS Lett. 1998, 438, 85-90.
36. 2+/ Calmodulin-Dependent Protein Kinase Enriched in Cerebellar Granule Cells. J. Biol. Chem. 1989, 264, 5866-5875.
37. Kitani, T.; Okuno, S.; Fujisawa, H. Cdna Cloning and Expression of Human Calmodulin-Dependent Protein Kinase Iv. J. Biochem. 1994, 115, 637-640.
38. 2+/Calmodulin-Dependent Protein Kinase Iv Expression in Epithelial Ovarian Cancer. Cancer Lett. 2002, 183, 185-193.
39. 2+/Calmodulin-Dependent Protein Kinase Inhibitor Kn-62(1-[N, O-Bis(5-Isoquinolinesulfonyl)-N-Methyl-L-Tyrosyl]-4- Phenylpiperazine) in Small Cell Lung Carcinoma. Biochem. Pharmacol. 1996, 51, 707-715.
40. 2+/Calmodulin-Dependent Protein Kinase Iv in Hepatocellular Carcinoma. Cancer 2000, 89, 1910-1916.
41. 2+/Calmodulin-Dependent Protein Kinase Iv During Pancreatic Acinar Stimulus-Secretion Coupling. Biochim. Biophys. Acta. 2000, 1497, 155-167.
42. Leprince, D.; Gegonne, A.; Coll, J.; de Taisne, C.; Schneeberger, A.; Lagrou, C.; Stehelin, D. A Putative Second Cell-Derived Oncogene of the Avian Leukemia Retrovirus E26. Nature 1983, 306, 395-397.
43. Nunn, M. F.; Seeburg, P. H.; Moscovici, C.; Duesberg, P. H. Tripartite Structure of the Avian Erythroblastosis Virus E26 Transforming Gene. Nature 1983, 306, 391-5.
44. Wasylyk, B.; Wasylyk, C.; Flores, P.; Begue, A.; Leprince, D.; Stehelin, D. The C-Ets Proto-Oncogene Encode Transcriptional Factors That Cooperate with C-Fos and C-Jun for Transcriptional Activation. Nature 1990, 346, 191-3.
45. Liotta, L. A.; Steeg, P. S.; Sttetler-Stevenson, W. G. Cancer Metastasis and Angiogenesis: An Imbalance of Positive and Negative Regulation. Cell 1991, 64, 327-36.
46. Nasu, K.; Kai, K.; Fujisawa, K.; Takai, N.; Nishida, Y.; Miyakawa, I. Expression of Cathepsin L in Normal Endometrium and Endometrial Cancer. Eur. J. Obstet. Gynecol. Reprod. Biol. 2001, 99, 102-105.
47. Takai, N.; Miyazaki, T.; Fujisawa, K; Nasu, K.; Miyakawa, I. Expression of C-Ets1 Is Associated with Malignant Potential in Endometrial Carcinoma. Cancer 2000, 89, 2059-2067.
48. Takai, N.; Miyazaki, T.; Nishida, M.; Nasu, K.; Miyakawa, I. C-Ets1 Is a Promising Marker in Epithelial Ovarian Cancer. Int. J. Mol. Med. 2002, 9, 287-292.
49. Takai, N.; Miyazaki, T.; Nishida, M.; Shang, S; Nasu, K.; Miyakawa, I. Clinical Relevance of Elf-1 Overexpression in Endometrial Carcinoma. Gynecol. Oncol. 2003, 89, 408-413.
50. Takai, N.; Miyazaki, T.; Nishida, M.; Nasu, K.; Miyakawa, I. The Significance of Elf-1 Expression in Epithelial Ovarian Carcinoma. Int. J. Mol. Med. 2003, 12, 349-354.
51. Tecimer, C.; Doering, D. L.; Goldsmith, L. J.; Meyer, J. S.; Abdulhay, G.; Wittliff, J. L. Clinical Relevance of Urokinase-Type Plasminogen Activator, Its Receptor, and Its Inhibitor Type 1 in Endometrial Cancer. Gynecol. Oncol. 2001, 80, 48-55.
52. Bredemeier-Ernst, I.; Nordheim, A.; Janknecht, R. Transcriptional Activity and Constitutive Nuclear Localization of the Ets Protein Elf-1. FEBS Lett. 1997, 408, 47-51.
53. Takai, N.; Miyazaki, T.; Nishida, M.; Nasu, K.; Miyakawa, I. Survivin Expression Correlates with Clinical Stage, Histological Grade, Invasive Behavior and Survival Rate in Endometrial Carcinoma. Cancer Lett. 2002, 184, 105-116.
54. Takai, N.; Miyazaki, T.; Nishida, M.; Nasu, K.; Miyakawa, I. Expression of Survivin Is Associated with Malignant Potential in Epithelial Ovarian Carcinoma. Int. J. Mol. Med. 2002, 10, 211-216.
55. Li, F.; Ambrosini, G.; Chu, E. Y.; Plescia, J.; Tognin, S.; Marchisio, P. C.; Altieri, D. C. Control of Apoptosis and Mitotic Spindle Checkpoint by Surviving. Nature 1998, 396, 580-584.
56. Garcia, I.; Martinou, I.; Tsujimoto, Y.; Martinou, J. C. Prevention of Programmed Cell Death of Sympathetic Neurons by the Bcl-2 Proto-Oncogene. Science 1992, 258, 302-304.
57. Du, C.; Fang, M.; Li, Y.; Li, L.; Wang, X. Smac, a Mitochondrial Protein That Promotes Cytochrome C-Dependent Caspase Activation by Eliminating lap Inhibition. Cell 2000, 102, 33-42.
58. Verhagen, A. M.; Ekert, P. G.; Pakusch, M.; Silke, J.; Connolly, L. M.; Reid, G. E.; Moritz, R. L.; Simpson, R. J.; Vaux, D. L. Identification of Diablo, a Mammalian Protein That Promotes Apoptosis by Binding to and Antagonizing IAP Proteins. Cell 2000, 102, 43-53.
59. Saitoh, Y.; Yaginuma, Y.; Ishikawa, M. Analysis of Bcl-2, Bax and Survivin Genes in Uterine Cancer. Int. J. Oncol. 1999, 15, 137-141.
60. Konno, R.; Yamakawa, H.; Utsunomiya, H.; Ito, K.; Sato, S.; Yajima, A. Expression of Survivin and Bcl-2 in the Normal Human Endometrium. Mol. Hum. Reprod. 2000, 6, 529-534.